Publications by authors named "Lisa Stott"

Claim this Profile
P
Preclinical pharmacokinetics, metabolism, and disposition of NXE0041178, a novel orally bioavailable agonist of the GPR52 receptor with potential for treatment of schizophrenia and related psychiatric disorders.
Simon Poulter, Nigel Austin, Stephen P Watson, Sarah J Bucknell, M Alistair O'Brien, Lisa A Stott

Xenobiotica· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Neutrophil Dynamic Mass Redistribution Assay as a Medium throughput Primary Cell Screening Assay.
Lisa A Stott, Armand Drieu la Rochelle, Susan Brown, Greg Osborne, Catherine J Hutchings

J Pharmacol Exp Ther· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Identification of GPR52 Agonist HTL0041178, a Potential Therapy for Schizophrenia and Related Psychiatric Disorders.
Simon Poulter, Nigel Austin, Rachel Armstrong, Matt Barnes, Sarah Joanne Bucknell, Lisa Alice Stott

ACS Med Chem Lett· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of inverse agonism of the orphan-G protein-coupled receptor GPR52 by cannabinoid ligands Cannabidiol and O-1918.
Lisa A Stott, Cheryl A Brighton, Jason Brown, Richard Mould, Kirstie A Bennett

Heliyon· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D receptors.
David A Sykes, Holly Moore, Lisa Stott, Nicholas Holliday, Jonathan A Javitch

Nat Commun· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unravelling intrinsic efficacy and ligand bias at G protein coupled receptors: A practical guide to assessing functional data.
Lisa A Stott, David A Hall, Nicholas D Holliday

Biochem Pharmacol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent and selective N-(4-sulfamoylphenyl)thiourea-based GPR55 agonists.
Sari Yrjölä, Teija Parkkari, Dina Navia-Paldanius, Tuomo Laitinen, Agnieszka A Kaczor, Lisa Stott

Eur J Med Chem· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis